MELAS KYRIAZI THEO 4
4 · Kaleido Biosciences, Inc. · Filed Aug 1, 2019
Insider Transaction Report
Form 4
MELAS KYRIAZI THEO
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-07-31+93,531→ 93,531 totalExercise: $7.67Exp: 2029-07-31→ Common Stock (93,531 underlying)
Footnotes (1)
- [F1]33% of this option shall vest on July 11, 2020, with the remainder vesting in 2 equal annual installments thereafter, subject to Mr. Melas-Kyriazi's continued service on the board of directors through each such date. This grant was made in accordance with the Company's Non-Employee Director Compensation Policy.